Points to consider in the clinical use of NGS panels for mitochondrial disease: An analysis of gene inclusion and consent forms

Journal of Genetic Counseling

Volumn 23, Issue 4, 2014, Pages 594-603

  Platt, Julia ^a   Cox, Rachel ^a   Enns, Gregory M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Clinical gene panel; Informed consent; Mitochondrial disease diagnostics; Mitochondrial NGS panel

Indexed keywords

GENETICS; HUMAN; INFORMED CONSENT; MITOCHONDRIAL DISEASES; PROCEDURES; RISK ASSESSMENT; SEQUENCE ANALYSIS;

HUMANS; INFORMED CONSENT; MITOCHONDRIAL DISEASES; RISK ASSESSMENT; SEQUENCE ANALYSIS;

EID: 84904264208     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-013-9683-2     Document Type: Article

References (22)

1. ACMG Board of Directors. (2012). Points to consider in the clinical application of genomic sequencing. Genetics in Medicine, 14(8), 759-761. doi: 10.1038/gim.2012.74.
2. Al-Chalabi, A.; Jones, A.; Troakes, C.; King, A.; Al-Sarraj, S.; van den Berg, L. H. (2012). The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathologica, 124(3), 339-352. doi: 10.1007/s00401-012-1022- 4.
3. Barletta, J. A.; Hornick, J. L. (2012). Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications. Advances in Anatomic Pathology, 19(4), 193-203. doi: 10.1097/PAP.0b013e31825c6bc6.
4. Bernier, F. P.; Boneh, A.; Dennett, X.; Chow, C. W.; Cleary, M. A.; Thorburn, D. R. (2002). Diagnostic criteria for respiratory chain disorders in adults and children. Neurology, 59(9), 1406-1411.
5. Biesecker, L. G. (2012). Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project. Genetics in Medicine, 14(4), 393-398. doi: 10.1038/gim.2011.78.
6. Calvo, S. E.; Mootha, V. K. (2010). The mitochondrial proteome and human disease. Annual Review of Genomics and Human Genetics, 11, 25-44. doi: 10.1146/annurev-genom-082509-141720.
7. Calvo, S. E.; Compton, A. G.; Hershman, S. G.; Lim, S. C.; Lieber, D. S.; Tucker, E. J.; et al. (2012). Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Science Translational Medicine, 4(118), 118ra110. doi: 10.1126/scitranslmed.3003310.
8. Delonlay, P.; Rötig, A.; Sarnat, H. B. (2013). Respiratory chain deficiencies. Handbook of Clinical Neurology, 113, 1651-1666. doi: 10.1016/B978-0-444-59565-2.00033-2.
9. DiMauro, S.; Schon, E. A. (2003). Mitochondrial respiratory-chain diseases. New England Journal of Medicine, 348(26), 2656-2668. doi: 10.1056/NEJMra022567.
10. Goldstein, A. C.; Bhatia, P.; Vento, J. M. (2013). Mitochondrial disease in childhood: nuclear encoded. Neurotherapeutics, 10(2), 212-226. doi: 10.1007/s13311-013-0185-6.
11. Green, R. C.; Berg, J. S.; Grody, W. W.; Kalia, S. S.; Korf, B. R.; Martin, C. L.; et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine. doi: 10.1038/gim.2013.73.
12. Jamal, S. M.; Yu, J. H.; Chong, J. X.; Dent, K. M.; Conta, J. H.; Tabor, H. K.; et al. (2013). Practices and policies of clinical exome sequencing providers: analysis and implications. American Journal of Medical Genetics Part A. doi: 10.1002/j.1552-4833.2013.35942.x.
13. Kirby, D. M.; Thorburn, D. R. (2008). Approaches to finding the molecular basis of mitochondrial oxidative phosphorylation disorders. Twin Research and Human Genetics, 11(4), 395-411. doi: 10.1375/twin.11.4.395.
14. McCormick, E.; Place, E.; Falk, M. J. (2013). Molecular genetic testing for mitochondrial disease: from one generation to the next. Neurotherapeutics, 10(2), 251-261. doi: 10.1007/s13311-012-0174-1.
15. Nunnari, J.; Suomalainen, A. (2012). Mitochondria: in sickness and in health. Cell, 148(6), 1145-1159. doi: 10.1016/j.cell.2012.02.035.
16. Pagliarini, D. J.; Calvo, S. E.; Chang, B.; Sheth, S. A.; Vafai, S. B.; Ong, S. E.; et al. (2008). A mitochondrial protein compendium elucidates complex I disease biology. Cell, 134(1), 112-123. doi: 10.1016/j.cell.2008.06.016.
17. Rosen, D. R. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 364(6435), 362. doi: 10.1038/364362c0.
18. Ross, L. F.; Saal, H. M.; David, K. L.; Anderson, R. R.; American Academy of Pediatrics; American College of Medical Genetics and Genomics. (2013). Technical report: ethical and policy issues in genetic testing and screening of children. Genetics in Medicine, 15(3), 234-245. doi: 10.1038/gim.2012.176.
19. Skladal, D.; Halliday, J.; Thorburn, D. R. (2003). Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain, 126(Pt 8), 1905-1912. doi: 10.1093/brain/awg170.
20. Tucker, E. J.; Compton, A. G.; Thorburn, D. R. (2010). Recent advances in the genetics of mitochondrial encephalopathies. Current Neurology and Neuroscience Reports, 10(4), 277-285. doi: 10.1007/s11910-010-0112-8.
21. Vento, J. M.; Pappa, B. (2013). Genetic counseling in mitochondrial disease. Neurotherapeutics, 10(2), 243-250. doi: 10.1007/s13311-012-0173-2.
22. Wong, L. J. (2013). Next generation molecular diagnosis of mitochondrial disorders. Mitochondrion, 13(4), 379-387. doi: 10.1016/j.mito.2013.02.001.